Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mingfeng Yu

Showing results (21-30 of 60) with videos related to

Pageof 6
Sort By:
Future Medicinal Chemistry|August 11, 2017
A novel series of N-(pyridin-2-yl)-4-(thiazol-5-yl)pyrimidin-2-amines as highly potent CDK4/6 inhibitorsSolomon Tadesse, Ge Zhu, Laychiluh B Mekonnen, et al.
The Journal of Nursing Research : JNR|December 5, 2022
Disaster Preparedness Among Nurses in China: A Cross-Sectional StudyYing Wang, Yu Liu, Mingfeng Yu, et al.
Chemistryopen|February 20, 2014
Incorporation of Bulky and Cationic Cyclam-Triazole Moieties into Marimastat Can Generate Potent MMP Inhibitory Activity without Inducing CytotoxicityMingfeng Yu, Ngee H Lim, Samantha Ellis, et al.
Future Medicinal Chemistry|October 28, 2017
CDK5 in oncology: recent advances and future prospectsJimma Likisa Lenjisa, Solomon Tadesse, Nishat Zareen Khair, et al.
Plos One|July 2, 2014
Incorporating a piperidinyl group in the fluorophore extends the fluorescence lifetime of click-derived cyclam-naphthalimide conjugatesMingfeng Yu, Sandra Ast, Qun Yu, et al.
European Journal of Medicinal Chemistry|March 25, 2015
Discovery of 4-(dihydropyridinon-3-yl)amino-5-methylthieno[2,3-d]pyrimidine derivatives as potent Mnk inhibitors: synthesis, structure-activity relationship analysis and biological evaluationMingfeng Yu, Peng Li, Sunita K C Basnet, et al.
Future Medicinal Chemistry|January 14, 2015
Targeting Pim kinases for cancer treatment: opportunities and challengesBich Thuy Le, Malika Kumarasiri, Julian R J Adams, et al.
Molecular Pharmacology|June 6, 2015
Pharmacologic Inhibition of MNKs in Acute Myeloid LeukemiaTheodosia Teo, Frankie Lam, Mingfeng Yu, et al.
Metallomics : Integrated Biometal Science|August 19, 2014
Neuroprotective peptide-macrocycle conjugates reveal complex structure-activity relationships in their interactions with amyloid βMingfeng Yu, Timothy M Ryan, Samantha Ellis, et al.
Endocrine-Related Cancer|September 2, 2016
Targeting CDK9: a promising therapeutic opportunity in prostate cancerMuhammed H Rahaman, Malika Kumarasiri, Laychiluh B Mekonnen, et al.
Pageof 6

Showing results (21-30 of 60) with videos related to

Sort By:
Pageof 6
Future Medicinal Chemistry|August 11, 2017
A novel series of N-(pyridin-2-yl)-4-(thiazol-5-yl)pyrimidin-2-amines as highly potent CDK4/6 inhibitorsSolomon Tadesse, Ge Zhu, Laychiluh B Mekonnen, et al.
The Journal of Nursing Research : JNR|December 5, 2022
Disaster Preparedness Among Nurses in China: A Cross-Sectional StudyYing Wang, Yu Liu, Mingfeng Yu, et al.
Chemistryopen|February 20, 2014
Incorporation of Bulky and Cationic Cyclam-Triazole Moieties into Marimastat Can Generate Potent MMP Inhibitory Activity without Inducing CytotoxicityMingfeng Yu, Ngee H Lim, Samantha Ellis, et al.
Future Medicinal Chemistry|October 28, 2017
CDK5 in oncology: recent advances and future prospectsJimma Likisa Lenjisa, Solomon Tadesse, Nishat Zareen Khair, et al.
Plos One|July 2, 2014
Incorporating a piperidinyl group in the fluorophore extends the fluorescence lifetime of click-derived cyclam-naphthalimide conjugatesMingfeng Yu, Sandra Ast, Qun Yu, et al.
European Journal of Medicinal Chemistry|March 25, 2015
Discovery of 4-(dihydropyridinon-3-yl)amino-5-methylthieno[2,3-d]pyrimidine derivatives as potent Mnk inhibitors: synthesis, structure-activity relationship analysis and biological evaluationMingfeng Yu, Peng Li, Sunita K C Basnet, et al.
Future Medicinal Chemistry|January 14, 2015
Targeting Pim kinases for cancer treatment: opportunities and challengesBich Thuy Le, Malika Kumarasiri, Julian R J Adams, et al.
Molecular Pharmacology|June 6, 2015
Pharmacologic Inhibition of MNKs in Acute Myeloid LeukemiaTheodosia Teo, Frankie Lam, Mingfeng Yu, et al.
Metallomics : Integrated Biometal Science|August 19, 2014
Neuroprotective peptide-macrocycle conjugates reveal complex structure-activity relationships in their interactions with amyloid βMingfeng Yu, Timothy M Ryan, Samantha Ellis, et al.
Endocrine-Related Cancer|September 2, 2016
Targeting CDK9: a promising therapeutic opportunity in prostate cancerMuhammed H Rahaman, Malika Kumarasiri, Laychiluh B Mekonnen, et al.
Pageof 6